The role of TLR4 in photoreceptor {alpha}a crystallin upregulation during early experimental autoimmune uveitis.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 2904017)

Published in Invest Ophthalmol Vis Sci on March 05, 2010

Authors

Sindhu Saraswathy1, Angeline M Nguyen, Narsing A Rao

Author Affiliations

1: Doheny Eye Institute, Department of Ophthalmology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 23.92

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity (1999) 17.40

Toll-like receptors and innate immunity. Nat Rev Immunol (2001) 16.50

Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46

Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem (2000) 3.06

Crystallins in the eye: Function and pathology. Prog Retin Eye Res (2007) 2.57

Toll-like receptors as potential therapeutic targets for multiple diseases. Nat Rev Drug Discov (2002) 1.75

Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice. Nat Immunol (2002) 1.73

Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res (2007) 1.73

Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J (2005) 1.72

Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J Immunol (2005) 1.50

Role of oxygen free radicals in retinal damage associated with experimental uveitis. Trans Am Ophthalmol Soc (1990) 1.47

Comparison of clinical and experimental uveitis. Curr Eye Res (1990) 1.44

A comprehensive analysis of the expression of crystallins in mouse retina. Mol Vis (2003) 1.43

Rodent models of experimental autoimmune uveitis. Methods Mol Med (2004) 1.43

Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int Rev Immunol (2002) 1.38

Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt. Cell Biol Int (2009) 1.37

Elevated retina-specific expression of the small heat shock protein, alphaA-crystallin, is associated with photoreceptor protection in experimental uveitis. Invest Ophthalmol Vis Sci (2008) 1.30

Bench to bedside: new approaches to the immunotherapy of uveitic disease. Int Rev Immunol (2002) 1.28

Stress, aging, and neurodegenerative disease. N Engl J Med (2006) 1.18

Toll-like receptors and inflammation in the CNS. Curr Drug Targets Inflamm Allergy (2002) 1.15

Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats. Curr Eye Res (1998) 1.14

Modified alpha A crystallin in the retina: altered expression and truncation with aging. Biochemistry (2003) 1.14

Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology (2000) 1.13

Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. J Immunol (1997) 1.09

Free radical mediated photoreceptor damage in uveitis. Prog Retin Eye Res (2000) 1.08

Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis. Br J Ophthalmol (2006) 1.02

Pathogenic role of retinal microglia in experimental uveoretinitis. Invest Ophthalmol Vis Sci (2003) 1.00

Pertussis toxin is superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and their cytokine production. J Immunol (2006) 0.98

Mitochondrial oxidative DNA damage in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2008) 0.97

Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors. Croat Med J (2008) 0.93

Photoreceptor mitochondrial oxidative stress in experimental autoimmune uveitis. Ophthalmic Res (2008) 0.90

Internally elongated rodent alpha-crystallin A chain: resulting from incomplete RNA splicing? Biochem Biophys Res Commun (1980) 0.89

Increased mitochondrial DNA oxidative damage after transient middle cerebral artery occlusion in mice. Neurosci Res (2007) 0.89

Photoreceptor mitochondrial tyrosine nitration in experimental uveitis. Invest Ophthalmol Vis Sci (2005) 0.88

Differential expression of nitric oxide synthase in experimental uveoretinitis. Invest Ophthalmol Vis Sci (1999) 0.87

Increased nitric oxide synthase activity as a cause of mitochondrial dysfunction in rat hepatocytes: roles for tumor necrosis factor alpha. Hepatology (1996) 0.86

[Uveitis. A status assessment]. Fortschr Ophthalmol (1990) 0.76

Articles by these authors

(truncated to the top 100)

Intraocular tuberculosis--an update. Surv Ophthalmol (2007) 5.18

Ab interno trabeculectomy: development of a novel device (Trabectome) and surgery for open-angle glaucoma. J Glaucoma (2006) 2.91

Syphilis: reemergence of an old adversary. Ophthalmology (2006) 2.81

International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm (2009) 2.47

Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol (2002) 1.75

Solitary fibrous tumor of the orbit: a clinicopathologic study of six cases with review of the literature. Surv Ophthalmol (2003) 1.73

Association of herpesviruses in the aqueous humor of patients with serpiginous choroiditis: a polymerase chain reaction-based study. Ocul Immunol Inflamm (2002) 1.50

Recommendations for the reporting of tissues removed as part of the surgical treatment of common malignancies of the eye and its adnexa. Mod Pathol (2003) 1.44

Neoplastic masquerade syndromes. Surv Ophthalmol (2002) 1.42

International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm (2008) 1.38

Anti-tubercular treatment is not required in latent tuberculosis. Br J Ophthalmol (2012) 1.38

Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology (2010) 1.37

Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology (2005) 1.33

Vogt-Koyanagi-Harada disease in patients with chronic hepatitis C. Am J Ophthalmol (2005) 1.31

Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm (2009) 1.25

Presumed Vogt-Koyanagi-Harada disease with unilateral ocular involvement: report of three cases. Graefes Arch Clin Exp Ophthalmol (2009) 1.23

Interferon-gamma release assays in the diagnosis of tuberculous uveitis. Am J Ophthalmol (2008) 1.23

Nontuberculous mycobacterial ocular and adnexal infections. Surv Ophthalmol (2012) 1.23

Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. Invest Ophthalmol Vis Sci (2003) 1.22

Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol (2013) 1.19

A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology (2002) 1.18

Clinical features of tuberculous serpiginouslike choroiditis in contrast to classic serpiginous choroiditis. Arch Ophthalmol (2010) 1.15

Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol (2006) 1.14

Presumed trematode-induced granulomatous anterior uveitis: a newly recognized cause of intraocular inflammation in children from south India. Am J Ophthalmol (2002) 1.12

Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature. Ocul Immunol Inflamm (2010) 1.09

Expression of vascular endothelial growth factor in eyes with Coats' disease. Invest Ophthalmol Vis Sci (2013) 1.09

Bartonella henselae infection presenting as a unilateral panuveitis simulating Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol (2004) 1.09

Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis. PLoS One (2011) 1.09

Work-up, diagnosis and management of acute Vogt-Koyanagi-Harada disease: a case of acute myopization with granulomatous uveitis. Int Ophthalmol (2007) 1.08

Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin (2005) 1.07

Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci (2012) 1.07

Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis. Br J Ophthalmol (2006) 1.02

Ultra-wide-field green-light (532-nm) autofluorescence imaging in chronic Vogt-Koyanagi-Harada disease. Ophthalmic Surg Lasers Imaging (2011) 1.01

Sympathetic ophthalmia following postoperative bacterial endophthalmitis: a clinicopathologic study. Am J Ophthalmol (2006) 1.01

The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits. Invest Ophthalmol Vis Sci (2007) 1.01

Conjunctival ulcers in Behçet's disease. Ophthalmology (2003) 1.01

Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy. Ophthalmol Clin North Am (2002) 1.00

Lattice corneal dystrophy associated with the Ala546Asp and Pro551Gln missense changes in the TGFBI gene. Am J Ophthalmol (2004) 0.99

The diagnosis and management of anterior scleritis. Int Ophthalmol Clin (2005) 0.99

Natural course of experimental retinal vein occlusion in rabbit; arterial occlusion following venous photothrombosis. Graefes Arch Clin Exp Ophthalmol (2008) 0.98

Morphometric spectral-domain optical coherence tomography features of epiretinal membrane correlate with visual acuity in patients with uveitis. Am J Ophthalmol (2012) 0.97

Changing causes of enucleation over the past 60 years. Graefes Arch Clin Exp Ophthalmol (2009) 0.97

Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings. Retina (2010) 0.97

Mitochondrial oxidative DNA damage in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2008) 0.97

Neuroglobin in normal retina and retina from eyes with advanced glaucoma. Br J Ophthalmol (2006) 0.95

Dark hypopyon in Streptococcus bovis endogenous endophthalmitis: clinicopathologic correlations. J Ophthalmic Inflamm Infect (2010) 0.95

Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology (2006) 0.94

Role of ultra-widefield fluorescein angiography in the management of uveitis. Can J Ophthalmol (2013) 0.93

Mitochondrial proteomics in experimental autoimmune uveitis oxidative stress. Invest Ophthalmol Vis Sci (2009) 0.93

Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis. Ophthalmology (2005) 0.93

Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease. Br J Ophthalmol (2012) 0.92

HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California. Hum Immunol (2004) 0.91

Endoretinal biopsy in establishing the diagnosis of uveitis: a clinicopathologic report of three cases. Ocul Immunol Inflamm (2005) 0.90

Photoreceptor mitochondrial oxidative stress in experimental autoimmune uveitis. Ophthalmic Res (2008) 0.90

Expression of alpha-crystallin in retinoblastoma. Arch Ophthalmol (2009) 0.89

Splendore-Hoeppli phenomenon in the conjunctiva: immunohistochemical analysis. Am J Ophthalmol (2005) 0.89

Early surgical debridement in the management of infectious scleritis after pterygium excision. J Ophthalmic Inflamm Infect (2012) 0.89

Update of ocular manifestations in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2002) 0.89

Isolated uveal tuberculoma masquerading as an intraocular tumor in an immunocompetent patient-a clinical-pathologic study with diagnosis by PCR. J Ophthalmic Inflamm Infect (2010) 0.88

Neuroglobin protection in retinal ischemia. Invest Ophthalmol Vis Sci (2012) 0.88

Photoreceptor mitochondrial tyrosine nitration in experimental uveitis. Invest Ophthalmol Vis Sci (2005) 0.88

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. Hum Immunol (2008) 0.88

The role of TLR4 activation in photoreceptor mitochondrial oxidative stress. Invest Ophthalmol Vis Sci (2011) 0.88

Human leukocyte antigen A29 subtypes associated with birdshot retinochoroidopathy. Am J Ophthalmol (2004) 0.87

Keloid of the conjunctiva simulating a conjunctival malignancy. Br J Ophthalmol (2007) 0.87

Massive mycobacterial choroiditis during highly active antiretroviral therapy: another immune-recovery uveitis? Ophthalmology (2002) 0.87

Simultaneous presentation of Kimura disease and angiolymphoid hyperplasia with eosinophilia. Ophthal Plast Reconstr Surg (2008) 0.87

Mitochondrial oxidative stress initiates visual loss in sympathetic ophthalmia. Jpn J Ophthalmol (2012) 0.86

Morphometric analysis of optic nerves and retina from an end-stage retinitis pigmentosa patient with an implanted active epiretinal array. Invest Ophthalmol Vis Sci (2011) 0.85

Retinal microglial activation and chemotaxis by docosahexaenoic acid hydroperoxide. Invest Ophthalmol Vis Sci (2006) 0.85

Increased expression of αA-crystallin in human diabetic eye. Int J Mol Med (2011) 0.85

Immunopathologic processes in sympathetic ophthalmia as signified by microRNA profiling. Invest Ophthalmol Vis Sci (2012) 0.84

Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol (2005) 0.84

Photoreceptor oxidative damage in sympathetic ophthalmia. Am J Ophthalmol (2008) 0.84

Periorbital xanthogranuloma after blepharoplasty. Br J Ophthalmol (2007) 0.83

Myxofibrosarcoma of the orbit: an underrecognized entity? Case report and review of the literature. Ophthalmology (2007) 0.83

Pigmented malignant medulloepithelioma of the ciliary body. J Pediatr Ophthalmol Strabismus (2004) 0.82

Salivary duct carcinoma metastatic to eyelid and orbit-a case report. Graefes Arch Clin Exp Ophthalmol (2008) 0.82

Eosinophilic variant of Wegener granulomatosis in the orbit. Arch Ophthalmol (2011) 0.82

Xanthogranuloma of the iris simulating melanoma in an adult. Am J Ophthalmol (2006) 0.82

Immunohistochemical study of chronic nongranulomatous anterior uveitis in juvenile idiopathic arthritis. Ophthalmology (2008) 0.82

Utility of lumbar puncture in diagnosis of Vogt-Koyanagi-Harada disease. Int Ophthalmol (2007) 0.81

Pseudotumoral retinal pigment epithelium proliferation in a patient with Vogt-Koyanagi-Harada disease. Arch Ophthalmol (2006) 0.81

Atypical infectious nodular scleritis. Arch Ophthalmol (2009) 0.81

Detection of histoplasma capsulatum DNA in lesions of chronic ocular histoplasmosis syndrome. Arch Ophthalmol (2003) 0.81

Merkel cell carcinoma of the conjunctiva. Ophthalmology (2010) 0.81

Immunopathology of necrotising scleritis. Br J Ophthalmol (2008) 0.81

Uveitis in developing countries. Indian J Ophthalmol (2013) 0.81

Vogt-Koyanagi-Harada disease in Hispanic patients. Int Ophthalmol (2007) 0.81

Peroxynitrite-induced apoptosis in photoreceptor cells. Curr Eye Res (2004) 0.81

Transforming growth factor beta in retinoblastoma-related cataract. Arch Ophthalmol (2008) 0.81

Posttranslational modification of differentially expressed mitochondrial proteins in the retina during early experimental autoimmune uveitis. Mol Vis (2011) 0.81

Effects of a new dexamethasone-delivery system (Surodex) on experimental intraocular inflammation models. Graefes Arch Clin Exp Ophthalmol (2003) 0.81

An unusual clinical phenotype of Avellino corneal dystrophy associated with an Arg124His beta iG-H3 mutation in an African-American woman. Am J Ophthalmol (2004) 0.81

Recommendations for the reporting of tissues removed as part of the surgical treatment of common malignancies of the eye and its adnexa. Am J Surg Pathol (2003) 0.80

Limited macular translocation: a clinicopathologic case report. Ophthalmology (2004) 0.79

Phenotype of transgenic mice overexpressed with inducible nitric oxide synthase in the retina. PLoS One (2012) 0.79

Photodynamic therapy with verteporfin for serpiginous choroiditis with subfoveal choroidal neovascularization. Retin Cases Brief Rep (2007) 0.79

Expression of α-crystallin in the retina of human sympathetic ophthalmia. Mol Med Rep (2011) 0.79

Osseous choristoma of the conjunctiva simulating extraocular extension of retinoblastoma. Am J Ophthalmol (2002) 0.79